Adam Wolkin

3.3k total citations
42 papers, 2.6k citations indexed

About

Adam Wolkin is a scholar working on Psychiatry and Mental health, Radiology, Nuclear Medicine and Imaging and Cognitive Neuroscience. According to data from OpenAlex, Adam Wolkin has authored 42 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 19 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Cognitive Neuroscience. Recurrent topics in Adam Wolkin's work include Schizophrenia research and treatment (21 papers), Functional Brain Connectivity Studies (16 papers) and Advanced Neuroimaging Techniques and Applications (11 papers). Adam Wolkin is often cited by papers focused on Schizophrenia research and treatment (21 papers), Functional Brain Connectivity Studies (16 papers) and Advanced Neuroimaging Techniques and Applications (11 papers). Adam Wolkin collaborates with scholars based in United States, Australia and Italy. Adam Wolkin's co-authors include John Rotrosen, Jonathan D. Brodie, Michael Sanfilipo, Henry Rusinek, Alfred P. Wolf, Andrew Lautin, Robert Cancro, Kelvin O. Lim, Steven Choi and Judith Jaeger and has published in prestigious journals such as American Journal of Psychiatry, Annals of Neurology and Biological Psychiatry.

In The Last Decade

Adam Wolkin

40 papers receiving 2.5k citations

Peers

Countries citing papers authored by Adam Wolkin

Since Specialization

Citations

This map shows the geographic impact of Adam Wolkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Wolkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Wolkin more than expected).

Fields of papers citing papers by Adam Wolkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Wolkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Wolkin. The network helps show where Adam Wolkin may publish in the future.

Co-authorship network of co-authors of Adam Wolkin

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Wolkin. A scholar is included among the top collaborators of Adam Wolkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Wolkin. Adam Wolkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia	Schizophrenia Research	Monte S. Buchsbaum, M. Mehmet Haznedar et al.	31
2	Inferior Frontal White Matter Anisotropy and Negative Symptoms of Schizophrenia: A Diffusion Tensor Imaging Study	American Journal of Psychiatry	Adam Wolkin, Steven Choi et al.	133
3	Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms	Psychiatry Research Neuroimaging	Michael Sanfilipo, Henry Rusinek et al.	112
4	Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study	Biological Psychiatry	Kelvin O. Lim, Steven Choi et al.	161
5	Fine Volumetric Analysis of the Cerebral Ventricular System in Schizophrenia: Further Evidence for Multifocal Mild to Moderate Enlargement	Schizophrenia Bulletin	Michael Sanfilipo, Luigi Arena et al.	23
6	Structural Magnetic Resonance Image Averaging in Schizophrenia	American Journal of Psychiatry	Adam Wolkin, Henry Rusinek et al.	52
7	Effect of a Haloperidol Challenge on Regional Brain Metabolism in Neuroleptic-Responsive and Nonresponsive Schizophrenic Patients	American Journal of Psychiatry	Elsa J. Bartlett, Jonathan D. Brodie et al.	51
8	The Study of Neurotransmitter Interactions Using Positron Emission Tomography and Functional Coupling	Clinical Neuropharmacology	Philip Simkowitz, Elsa J. Bartlett et al.	15
9	Amphetamine and negative symptoms of schizophrenia	Psychopharmacology	Michael Sanfilipo, Adam Wolkin et al.	39
10	Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET study	European Archives of Psychiatry and Clinical Neuroscience	Jonathan D. Brodie, Elsa J. Bartlett et al.	33
11	Acute d-amphetamine challenge in schizophrenia: Effects on cerebral glucose utilization and clinical symptomatology	Biological Psychiatry	Adam Wolkin, Michael Sanfilipo et al.	35
12	Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function	Journal of Neural Transmission	Adam Wolkin, Elizabeth A. Duncan et al.	6
13	Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics	Biological Psychiatry	Erica Duncan, Adam Wolkin et al.	17
14	Elevated PLA2 activity in schizophrenics and other psychiatric patients	Biological Psychiatry	Michael Sanfilipo, Grant N. Ko et al.	114
15	Negative Symptoms and Hypofrontality in Chronic Schizophrenia	Archives of General Psychiatry	Adam Wolkin	324
16	Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia	Psychiatry Research Neuroimaging	Elsa J. Bartlett, F Barouche et al.	32
17	Importance of pharmacologic control in PET studies: Effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia	Psychiatry Research Neuroimaging	Elsa J. Bartlett, Adam Wolkin et al.	57
18	Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients	Biological Psychiatry	Michael Smith, Alfred P. Wolf et al.	104
19	Regional glucose metabolism in chronic schizophrenia.	PubMed	Jonathan D. Brodie, Adam Wolkin et al.	0
20	Patterns of metabolic activity in the treatment of schizophrenia	Annals of Neurology	Jonathan D. Brodie, David R. Christman et al.	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact